Switch theme
Sign up to access all valuation multiples
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
1961
6.3K+
Last FY Revenue $1.9B
Last FY EBITDA $73.9M
$425M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Profarma Distribuidora achieved revenue of $1.9B and an EBITDA of $73.9M.
Profarma Distribuidora expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Profarma Distribuidora valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.9B | XXX | XXX | XXX |
| Gross Profit | XXX | $280M | XXX | XXX | XXX |
| Gross Margin | XXX | 15% | XXX | XXX | XXX |
| EBITDA | XXX | $73.9M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 4% | XXX | XXX | XXX |
| EBIT | XXX | $46.8M | XXX | XXX | XXX |
| EBIT Margin | XXX | 3% | XXX | XXX | XXX |
| Net Profit | XXX | $21.1M | XXX | XXX | XXX |
| Net Margin | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | $105M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Profarma Distribuidora's stock price is BRL 8 (or $1).
Profarma Distribuidora has current market cap of BRL 980M (or $180M), and EV of BRL 2.3B (or $425M).
See Profarma Distribuidora trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $425M | $180M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Profarma Distribuidora has market cap of $180M and EV of $425M.
Profarma Distribuidora's trades at 0.2x EV/Revenue multiple, and 5.8x EV/EBITDA.
Equity research analysts estimate Profarma Distribuidora's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Profarma Distribuidora's P/E ratio is not available.
See valuation multiples for Profarma Distribuidora and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $180M | XXX | $180M | XXX | XXX | XXX |
| EV (current) | $425M | XXX | $425M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 5.8x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 9.1x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 8.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 4.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialProfarma Distribuidora's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $37K for the same period.
Profarma Distribuidora's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Profarma Distribuidora's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Profarma Distribuidora and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $37K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Dimed Distribuidora | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Profarma Distribuidora acquired XXX companies to date.
Last acquisition by Profarma Distribuidora was XXXXXXXX, XXXXX XXXXX XXXXXX . Profarma Distribuidora acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Profarma Distribuidora founded? | Profarma Distribuidora was founded in 1961. |
| Where is Profarma Distribuidora headquartered? | Profarma Distribuidora is headquartered in Brazil. |
| How many employees does Profarma Distribuidora have? | As of today, Profarma Distribuidora has 6.3K+ employees. |
| Is Profarma Distribuidora publicy listed? | Yes, Profarma Distribuidora is a public company listed on BVMF. |
| What is the stock symbol of Profarma Distribuidora? | Profarma Distribuidora trades under PFRM3 ticker. |
| When did Profarma Distribuidora go public? | Profarma Distribuidora went public in 2006. |
| Who are competitors of Profarma Distribuidora? | Similar companies to Profarma Distribuidora include e.g. MedPlus India, SC Ropharma, Pague Menos, Dimed Distribuidora. |
| What is the current market cap of Profarma Distribuidora? | Profarma Distribuidora's current market cap is $180M |
| Is Profarma Distribuidora profitable? | Yes, Profarma Distribuidora is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
